News

Nepali mixed martial artist Ravindra Dhat has captured national and international attention after he won the bantamweight ...
Following a barrage of letters from President Donald Trump urging 17 large pharmaceutical companies to implement Most Favored ...
Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...
US President Donald Trump recently announced tariffs as high as 100% on certain semiconductor products. Although South Korea ...
The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to ...
It’s a bad time to try to predict future pharmaceutical prices.
German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.
The Trump Administration is pursuing decidedly anti-growth policies. The results will be a weaker economy that violates his ...
Aside from the MFN order, President Trump is also in the process of negotiating tariffs with countries all over the world. It ...
Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...
MFN would also put drug access and innovation at risk. Under current law, manufacturers must participate in both Medicaid and 340B in order to access Medicare Part B, which covers doctors ...